CD8型
单变量分析
结直肠癌
免疫系统
细胞毒性T细胞
淋巴细胞
流式细胞术
免疫学
癌
肿瘤浸润淋巴细胞
免疫分型
生物
医学
内科学
肿瘤科
作者
Johanna Waidhauser,Pia Nerlinger,Tim Tobias Arndt,Stefan Schiele,Florian Sommer,Sebastian Wolf,Phillip Löhr,Stefan Eser,Gernot Müller,Rainer Claus,Bruno Märkl,Andreas Rank
标识
DOI:10.1007/s00262-021-03127-8
摘要
Abstract Introduction Cellular immune response to cancer is known to be of great importance for tumor control. Moreover, solid tumors influence circulating lymphocytes, which has been shown for several types of cancer. In our prospective study we elucidate changes in lymphocyte subsets in patients with colorectal carcinoma compared to healthy volunteers. Methods Flow cytometry was performed at diagnosis of colon carcinoma to analyze B cells, T cells and NK cells including various subtypes of each group. Univariate and multivariate analyses including age, gender, tumor stage, sidedness and microsatellite instability status (MSI) were performed. Results Forty-seven patients and 50 healthy volunteers were included. Median age was 65 years in patients and 43 years in the control group. Univariate analysis revealed lower total lymphocyte counts, lower CD4 + cells, CD8 + cells, B cells and NKs including various of their subsets in patients. In multivariate analysis patients had inferior values of B cells, CD4 + cells and NK cells and various subsets, regardless of age and gender. Naïve, central memory and HLADR + CD8 + cells showed an increase in patients whereas all other altered subsets declined. MSI status had no influence on circulating lymphocytes except for higher effector memory CD8 + cells in MSI-high patients. Localization in the left hemicolon led to higher values of total cytotoxic T cells and various T cell subsets. Conclusion We found significant changes in circulating lymphocyte subsets in colon carcinoma patients, independent of physiological alterations due to gender or age. For some lymphocyte subsets significant differences according to tumor localization or MSI-status could be seen.
科研通智能强力驱动
Strongly Powered by AbleSci AI